Chunxiao He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chunxiao He has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jialin Mm Shi
School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China
1 shared publication - Jun- Hao Zhou
Shaoxing Traditional Chinese Medicine Hospital , Shaoxing 312000 , Zhejiang , China
1 shared publication - Ruinan Gu
School of Medicine, Shaoxing University , Shaoxing 312000 , Zhejiang , China
1 shared publication - Yu Jiang
School of Medicine, Shaoxing University , Shaoxing 312000 , Zhejiang , China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 18 (1) , 20220692
ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is the most common and fatal diffuse fibrotic lung disease accompanied by macrophage M2 activation. ErbB4 is involved in and affects the process of inflammation. In this study, we determined that the mRNA level and protein expression of ErbB4 and M2 cytokine members were increased in the serum of IPF patients. In mouse alveolar macrophage MH-S cells, after knocking down ErbB4 by siRNA, the mRNA level and protein expression of M2 activator induced by interleukin (IL)-4 were decreased compared with the control group. Activating by ErbB4 agonist neuromodulatory protein (NRG)-1, IL-4-induced M2 program was promoted. Mechanistically, treated with NRG-1 in MH-S cells, the phosphorylation level of Akt did not change, while the phosphorylation level of ERK increased. Using SCH772984 to inhibit ERK pathway, the increasing IL-4-induced M2 activation by NRG-1 was inhibited, and the high level of M2 activator protein expression and mRNA expression was restored. Collectively, our data support that ErbB4 and M2 programs are implicated in IPF, and ErbB4 participates in the regulation of M2 activation induced by IL-4 through the ERK pathway.
- 1 January 2023
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 18 (1) , 20220692
Open AccessErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is the most common and fatal diffuse fibrotic lung disease accompanied by macrophage M2 activation. ErbB4 is involved in and affects the process of inflammation. In this study, we determined that the mRNA level and protein expression of ErbB4 and M2 cytokine members were increased in the serum of IPF patients. In mouse alveolar macrophage MH-S cells, after knocking down ErbB4 by siRNA, the mRNA level and protein expression of M2 activator induced by interleukin (IL)-4 were decreased compared with the control group. Activating by ErbB4 agonist neuromodulatory protein (NRG)-1, IL-4-induced M2 program was promoted. Mechanistically, treated with NRG-1 in MH-S cells, the phosphorylation level of Akt did not change, while the phosphorylation level of ERK increased. Using SCH772984 to inhibit ERK pathway, the increasing IL-4-induced M2 activation by NRG-1 was inhibited, and the high level of M2 activator protein expression and mRNA expression was restored. Collectively, our data support that ErbB4 and M2 programs are implicated in IPF, and ErbB4 participates in the regulation of M2 activation induced by IL-4 through the ERK pathway.